Jonathan Sporn holds a BS from Duke University and an MD from the University of Miami. He has held leadership roles including Chief of Psychiatry in the Boston area, researcher at the NIH and Mass General Hospital, psychiatry and neurology researcher at Johnson & Johnson, and Clinical Disease Area Expert in Neuroscience at Pfizer. He previously founded Perception Neuroscience, which exited, and is now Founder of Gilgamesh Pharmaceuticals; he also serves as Assistant Professor of Psychiatry and Experimental Therapeutics at Columbia University.
Intro paths
JONATHAN went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
Their group partner at YC was Jared Friedman, General Partner at Y Combinator — the partner who ran Gilgamesh Pharmaceuticals's batch and knows the company first-hand. YC profile ↗
In turn, JONATHAN can intro founders to Gilgamesh Pharmaceuticals's investors below.
Gilgamesh Pharmaceuticals's investors · 10
Co-founders
